Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Icos reveals new cGMP-specific PDE inhibitors

Feb. 12, 1998

Antibradycardic M2 receptor antagonists prepared at Yamanouchi

Feb. 11, 1998

Inex acquires antisense assets from Lynx

Feb. 10, 1998

Captopril demonstrates antioxidant activity in new in vitro assay

Feb. 9, 1998

CV Therapeutics, Cleveland Clinic Foundation collaborate on study of CVT-313

Feb. 6, 1998

Corlopam finally on the market -- U.S. is country of first launch

Feb. 6, 1998

Interleukin-1: a potential target for the treatment of atherosclerosis

Feb. 6, 1998

Weekly fish consumption might reduce the risk of sudden cardiac death in men

Feb. 6, 1998

CardioGenesis receives EU approval to market cardiovascular device

Feb. 5, 1998

Tiazac approved for angina in U.S.

Feb. 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...